- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,071GBP
- Report
- May 2024
- 164 Pages
Global
From €5196EUR$5,450USD£4,437GBP
- Report
- September 2023
- 145 Pages
Global
From €2383EUR$2,499USD£2,035GBP
- Report
- January 2024
- 200 Pages
Global
From €3957EUR$4,150USD£3,379GBP
- Report
- June 2023
- 158 Pages
Global
From €2384EUR$2,500USD£2,035GBP
- Report
- September 2023
- 124 Pages
North America
From €2573EUR$2,699USD£2,197GBP
- Report
- March 2024
- 194 Pages
Global
From €3217EUR$3,374USD£2,747GBP
€3574EUR$3,749USD£3,052GBP
- Report
- October 2023
- 75 Pages
Global
From €5673EUR$5,950USD£4,844GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,628GBP
- Report
- October 2023
- 186 Pages
Global
From €5244EUR$5,500USD£4,478GBP
- Report
- March 2024
- 181 Pages
Global
From €3217EUR$3,374USD£2,747GBP
€3574EUR$3,749USD£3,052GBP
- Report
- March 2024
- 186 Pages
Global
From €3217EUR$3,374USD£2,747GBP
€3574EUR$3,749USD£3,052GBP
- Report
- May 2023
- 169 Pages
Global
From €2241EUR$2,350USD£1,913GBP
- Report
- March 2024
- 195 Pages
Global
From €3217EUR$3,374USD£2,747GBP
€3574EUR$3,749USD£3,052GBP
- Report
- May 2024
- 134 Pages
Global
From €6196EUR$6,499USD£5,291GBP
- Report
- October 2023
- 185 Pages
Global
From €4672EUR$4,900USD£3,989GBP
- Report
- January 2024
- 150 Pages
Global
From €4624EUR$4,850USD£3,949GBP
- Report
- November 2023
- 177 Pages
Global
From €4672EUR$4,900USD£3,989GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,628GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,628GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more